Literature DB >> 17522831

[Photodynamic therapy of cutaneous epithelial malignancies. An evidence-based review].

A Sidoroff1.   

Abstract

During the last years photodynamic therapy (PDT) has progressively established itself as a standard treatment for non-melanoma skin cancer. A number of clinical studies have demonstrated its efficacy--also compared to other treatment modalities--as well as good acceptance by patients and outstanding cosmetic results. For Bowen disease and superficial basal cell carcinoma, PDT can be regarded as the first-line non-invasive treatment. In the treatment of actinic keratoses PDT should be considered when cosmesis is crucial or in cases of field cancerization. In nodular basal cell carcinoma, effectiveness for lesions up to a thickness of 2 mm is well documented. In summary the evidence level seems sufficient to regard PDT as valuable treatment modality of which patients should not be deprived.

Entities:  

Mesh:

Year:  2007        PMID: 17522831     DOI: 10.1007/s00105-007-1348-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  36 in total

1.  Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study.

Authors:  A M Soler; T Warloe; J Tausjø; A Berner
Journal:  Acta Derm Venereol       Date:  1999-05       Impact factor: 4.437

2.  A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses.

Authors:  H A Kurwa; S A Yong-Gee; P T Seed; A C Markey; R J Barlow
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

3.  Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.

Authors:  Colin Morton; Michael Horn; Joyce Leman; Brigitte Tack; Christophe Bedane; Milan Tjioe; Sally Ibbotson; Abdallah Khemis; Peter Wolf
Journal:  Arch Dermatol       Date:  2006-06

4.  A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.

Authors:  A M Soler; T Warloe; A Berner; K E Giercksky
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

Review 5.  Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

Authors:  Colin A Morton; S B Brown; S Collins; S Ibbotson; H Jenkinson; H Kurwa; K Langmack; K McKenna; H Moseley; A D Pearse; M Stringer; D K Taylor; G Wong; L E Rhodes
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

6.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

Authors:  P G Calzavara-Pinton
Journal:  J Photochem Photobiol B       Date:  1995-07       Impact factor: 6.252

7.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.

Authors:  R M Szeimies; S Karrer; S Radakovic-Fijan; A Tanew; P G Calzavara-Pinton; C Zane; A Sidoroff; M Hempel; J Ulrich; T Proebstle; H Meffert; M Mulder; D Salomon; H C Dittmar; J W Bauer; K Kernland; L Braathen
Journal:  J Am Acad Dermatol       Date:  2002-08       Impact factor: 11.527

8.  ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy.

Authors:  Mitchel Goldman; Deborah Atkin
Journal:  J Cosmet Laser Ther       Date:  2003-06       Impact factor: 2.247

9.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.

Authors:  R Fink-Puches; H P Soyer; A Hofer; H Kerl; P Wolf
Journal:  Arch Dermatol       Date:  1998-07

Review 10.  Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.

Authors:  E W B Jeffes
Journal:  J Dermatolog Treat       Date:  2002       Impact factor: 3.359

View more
  1 in total

Review 1.  [Skin tumours of the facial area].

Authors:  M Braun-Falco
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.